A Clinical Study to Evaluate the Safety and Tolerability of JS001sc in Advanced Nasopharyngeal Carcinoma

NCT05751486 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Advanced Nasopharyngeal Carcinoma

Interventions

BIOLOGICAL: Toripalimab injection(subcutaneous)/JS001sc
BIOLOGICAL: Toripalimab injection(subcutaneous)/JS001sc
BIOLOGICAL: Toripalimab /JS001
BIOLOGICAL: Toripalimab injection(subcutaneous)/JS001sc

Sponsor

Shanghai Junshi Bioscience Co., Ltd.